Reverberations for Ebos in Chemist Warehouse reverse listing

Reverberations for Ebos in Chemist Warehouse reverse listing
Sigma shareholders might well ask themselves if they're paying too much. (Image: NZME)
Paul McBeth
Discount pharmacist Chemist Warehouse’s reverse takeover of drugmaker Sigma Healthcare to build Australia’s biggest pharmacy group won’t immediately dent Ebos Group and may even offer some opportunities down the road. The discount pharmacist found its route onto the Australian securities exchange (ASX) via a reverse listing of Sigma, where Sigma will borrow A$1 billion (NZ$1.07b) from ANZ and National Australia Bank, give A$700m of that to the Chemist Warehouse shareholders and issue them shares equivalent to 85.8% of the...

More Markets

Transpower cautious over hydro lake level rule changes
Markets

Transpower cautious over hydro lake level rule changes

Transpower can authorise hydro lakes to dip further.

Why this tech firm sees a Trump tariff opportunity
Markets The small cap wrap

Why this tech firm sees a Trump tariff opportunity

Plus IkeGPS' wins in the US, Trade Window targets trade war, TruScreen, and more.

US stocks surge on hopes of China trade deal
Markets

US stocks surge on hopes of China trade deal

Asian indexes closed mixed, while oil prices firmed.

AFP 9:30am
Fast-food sector in 'consolidation' stage: IbisWorld
Retail

Fast-food sector in 'consolidation' stage: IbisWorld

Higher costs are helping McDonald’s and KFC grab market share.